R1 RCM finalizes restatement, maintains financial outlook
CHICAGO - R1 RCM (NASDAQ:RCM) Inc., a prominent provider in healthcare technology solutions, has completed a comprehensive restatement of its financial statements, the company announced...
-
-
R1 RCM Completes Restatement of Previously Issued Financial Statements
R1 RCM Inc . (NASDAQ:RCM) (“R1”) (“Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers,...
-
R1 RCM Receives Nasdaq Delinquency Notice
R1 RCM Inc. (RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that, as...
-
Deutsche Bank maintains R1 RCM at 'buy' with a price target of $19.00
An analyst from Deutsche Bank maintained R1 RCM (NASDAQ: RCM) at 'buy' with a price target of $19.00 from a prior price target of %currency%%price%. Prior to this rating, R1 RCM had 14 buy...
-
R1 RCM to restate financials for 2021, 2022, and H1 2023 over errors
CHICAGO - R1 RCM (NASDAQ:RCM) Inc., a leading provider of technology-enabled revenue cycle management services for healthcare providers, announced today that it will restate its financial...
-
BofA Securities maintains R1 RCM at 'buy' with a price target of $19.00
An analyst from BofA Securities maintained R1 RCM (NASDAQ: RCM) at 'buy' with a price target of $19.00 from a prior price target of %currency%%price%. Prior to this rating, R1 RCM had 15...
-
Morgan Stanley maintains R1 RCM at 'equalweight' with a price target of $17.50
An analyst from Morgan Stanley maintained R1 RCM (NASDAQ: RCM) at 'equalweight' with a price target of $17.50 from a prior price target of %currency%%price%. Prior to this rating, R1 RCM...
-
Truist Securities maintains R1 RCM at 'buy' with a price target of $16.00
An analyst from Truist Securities maintained R1 RCM (NASDAQ: RCM) at 'buy' with a price target of $16.00 from a prior price target of %currency%%price%. Prior to this rating, R1 RCM had 15...
-
Canaccord Genuity maintains R1 RCM at 'buy' with a price target of $17.00
An analyst from Canaccord Genuity maintained R1 RCM (NASDAQ: RCM) at 'buy' with a price target of $17.00 from a prior price target of %currency%%price%. Prior to this rating, R1 RCM had 15...
-
RBC Capital maintains R1 RCM at 'outperform' with a price target of $19.00
An analyst from RBC Capital maintained R1 RCM (NASDAQ: RCM) at 'outperform' with a price target of $19.00 from a prior price target of %currency%%price%. Prior to this rating, R1 RCM had...
-
R1 RCM earnings beat by $0.11, revenue topped estimates
Investing.com - R1 RCM (NASDAQ: RCM) reported third quarter EPS of $0.19, $0.11 better than the analyst estimate of $0.08. Revenue for the quarter came in at $572.8M versus the consensus...
-
R1 RCM Expands Partnership with Microsoft
R1 RCM Inc. (RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced an expansion of...
-
Truist Upgrades R1 RCM Inc to Buy, 'disconnect between recent core fundamental operations and share price reaction provide an opportunity'
(Updated - October 19, 2023 4:47 AM EDT) Analysts at Truist Securities upgraded R1 RCM Inc (RCM) from Hold to Buy with a price target of $18.00.The analysts comment "R1 shares have been...
-
RCM Inc Defended at Citi, PT $20, 'We see the sell-off as a buying opportunity'
Analysts at Citi reiterated a Buy rating and $20.00 price target on R1 RCM Inc (RCM).The analysts comment "R1’s stock has had a tough go at it recently. The stock is down 22% in October...
-
Citi Reiterates Buy Rating on R1 RCM Inc , 'A More Nimble, Diversified RCM'
Citi analyst reiterated a Buy rating and $20.00 price target on R1 RCM Inc (RCM).The analyst comments "We are initiating on R1 with a Buy/High Risk rating and a $20 price target. In our...
-
R1 RCM Inc. sees growth despite trading at discount
R1 RCM Inc . (NASDAQ:RCM) saw a trading volume of 2.87 million shares in the last trading session, with the company's beta reaching 0.85. The company's market valuation stood at $6.99...
-
Cantor Fitzgerald initiates coverage of R1 RCM at 'overweight' with a price target of $20.00
An analyst from Cantor Fitzgerald initiated coverage of R1 RCM (NASDAQ: RCM) at 'overweight' with a price target of $20.00. Prior to this rating, R1 RCM had 13 buy ratings, 2 hold...
-
Truist Securities maintains R1 RCM at 'hold' with a price target of $18.00
An analyst from Truist Securities maintained R1 RCM (NASDAQ: RCM) at 'hold' with a price target of $18.00 from a prior price target of %currency%%price%. Prior to this rating, R1 RCM had...
-
Barclays maintains R1 RCM at 'overweight' with a price target of $20.00
An analyst from Barclays maintained R1 RCM (NASDAQ: RCM) at 'overweight' with a price target of $20.00 from a prior price target of %currency%%price%. Prior to this rating, R1 RCM had 14...
-
Morgan Stanley maintains R1 RCM at 'equalweight' with a price target of $19.00
An analyst from Morgan Stanley maintained R1 RCM (NASDAQ: RCM) at 'equalweight' with a price target of $19.00 from a prior price target of %currency%%price%. Prior to this rating, R1 RCM...
-
Deutsche Bank maintains R1 RCM at 'buy' with a price target of $22.00
An analyst from Deutsche Bank maintained R1 RCM (NASDAQ: RCM) at 'buy' with a price target of $22.00 from a prior price target of %currency%%price%. Prior to this rating, R1 RCM had 14 buy...
-
Evercore ISI maintains R1 RCM at 'outperform' with a price target of $21.00
An analyst from Evercore ISI maintained R1 RCM (NASDAQ: RCM) at 'outperform' with a price target of $21.00 from a prior price target of %currency%%price%. Prior to this rating, R1 RCM had...
-
R1 RCM earnings missed by $0.02, revenue fell short of estimates
Investing.com - R1 RCM (NASDAQ: RCM) reported second quarter EPS of $0.04, $0.02 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $560.7M versus the consensus...
-
Jefferies maintains R1 RCM at 'buy' with a price target of $22.00
An analyst from Jefferies maintained R1 RCM (NASDAQ: RCM) at 'buy' with a price target of $22.00 from a prior price target of %currency%%price%. Prior to this rating, R1 RCM had 13 buy...
-
RBC Capital maintains R1 RCM at 'outperform' with a price target of $22.00
An analyst from RBC Capital maintained R1 RCM (NASDAQ: RCM) at 'outperform' with a price target of $22.00 from a prior price target of %currency%%price%. Prior to this rating, R1 RCM had...
-
Deutsche Bank maintains R1 RCM at 'buy' with a price target of $18.00
An analyst from Deutsche Bank maintained R1 RCM (NASDAQ: RCM) at 'buy' with a price target of $18.00 from a prior price target of %currency%%price%. Prior to this rating, R1 RCM had 13 buy...
-
Morgan Stanley maintains R1 RCM at Equalweight, PT $16.00
A Morgan Stanley analyst maintained R1 RCM (NASDAQ: RCM) at Equalweight and a price target of $16.00 from a prior price target of %currency%%price%. Prior to this rating, R1 RCM had 13 buy...
-
Morgan Stanley maintains R1 RCM at Equalweight, PT $16.00
A Morgan Stanley analyst maintained R1 RCM (NASDAQ: RCM) at Equalweight and a price target of $16.00 from a prior price target of %currency%%price%. Prior to this rating, R1 RCM had 13 buy...
-
R1 RCM earnings missed by $0.02, revenue fell short of estimates
Investing.com - R1 RCM (NASDAQ: RCM) reported first quarter EPS of $0.01, $0.02 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $545.6M versus the consensus...
-
BofA Securities maintains R1 RCM at Buy
A BofA Securities analyst maintained R1 RCM (NASDAQ: RCM) at Buy and a price target of $19.00 from a prior price target of %currency%%price%. Prior to this rating, R1 RCM had 13 buy...
-
Stephens new coverage R1 RCM Overweight
A Stephens analyst initiated new coverage R1 RCM (NASDAQ: RCM) Overweight rating and a price target of $No data. Prior to this rating, R1 RCM had 11 buy ratings, 2 hold ratings, and 0...
-
Baird new coverage R1 RCM Outperform
A Baird analyst initiated new coverage R1 RCM (NASDAQ: RCM) Outperform rating and a price target of $18.00. Prior to this rating, R1 RCM had 11 buy ratings, 2 hold ratings, and 0 sell...
-
R1 RCM Misses Q4 EPS by 7c
R1 RCM (NASDAQ:RCM) reported Q4 EPS of ($0.09), $0.07 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $532.8 million versus the consensus estimate of $519.18...
-
R1 RCM earnings missed by $0.07, revenue topped estimates
Investing.com - R1 RCM (NASDAQ: RCM) reported fourth quarter EPS of $-0.09, $0.07 worse than the analyst estimate of $-0.02. Revenue for the quarter came in at $532.8M versus the consensus...
-
Today’s important price target changes
By Davit Kirakosyan JPMorgan lowered the price target on Take-Two Interactive (NASDAQ:TTWO) to $144.00 from $165.00 while maintaining an Overweight rating. Shares fell more than 13% today...
-
R1 RCM earnings, Revenue miss in Q3
Investing.com - R1 RCM reported on Tuesday third quarter {{erl-998046||earnings that missed analysts' forecasts and revenue that fell short of expectations. R1 RCM announced earnings per...
-
Today's Most Important Initiations
By Davit Kirakosyan Cantor Fitzgerald initiated coverage on WeWork Inc (NYSE:WE) with an Overweight rating and a price target of $8.00, noting it believes the company will be able to...
-
Pre-Open Movers: DocuSign, Zscaler Jumps Post EPS; Allakos Falls on Drug Data
Pre-Open Stock Movers:Digital Media Solutions, Inc. (DMS) 62% HIGHER; announced that its board of directors has received an offer from Prism Data, LLC, an investment vehicle affiliated with...
-
After-Hours Movers: DocuSign Jumps on EPS Beat, Zumiez Sinks on Miss
After-Hours Stock Movers:Digital Media Solutions, Inc. (DMS) 62% HIGHER; announced that its board of directors has received an offer from Prism Data, LLC, an investment vehicle affiliated...
-
R1 RCM Misses Q2 EPS by 18c
R1 RCM (NASDAQ:RCM) reported Q2 EPS of ($0.07), $0.18 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $391.9 million versus the consensus estimate of $391.78...
-
R1 RCM Misses Q1 EPS by 1c
R1 RCM (NASDAQ:RCM) reported Q1 EPS of $0.09, $0.01 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $385.7 million versus the consensus estimate of $384.19...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
